S. Coons

Cell · 2005–2015

A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Whom S. Coons trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Landis
  2. Subir Ghosh
  3. Gary G. Koch

Who trusts S. Coons overall

  1. P. Sullivan

Papers from S. Coons's perspective

Ordered by how strongly the researchers S. Coons trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Cost-effectiveness in health and medicine
  2. Final version of 2009 AJCC melanoma staging and classification. (Journal of Clinical Oncology)
  3. Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development.
  4. KIT as a therapeutic target in metastatic melanoma. (Journal of the American Medical Association (JAMA))
  5. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial. (The Lancet)
  6. The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. (Cancer Discovery)
  7. PD-1 blockade induces responses by inhibiting adaptive immune resistance (Nature)
  8. Multilevel Statistical Models
  9. Highly recurrent TERT promoter mutations in human melanoma (Science)
  10. TERT Promoter Mutations in Familial and Sporadic Melanoma (Science)

Their papers